NEWS DETAIL

Pendapat/Keputusan Berkenaan Program Penyelidikan Pediatrik (PIP): Jyseleca, Figoratinib Maleate, Jenis Keputusan: PM: Keputusan Berkenaan Pindaan kepada Aplikasi PIP yang Dipersetujui, Bidang Terapeutik: Penyakit Muskuloskeletal dan Tisu Penghubung, Nombor PIP: EMA/PE/0000232302

Alfasigma S.p.A.

Maklumat Perubatan

Kandungan penuh artikel

Related medicine information Alfasigma S. p. A. E-mail: medicalinfo@alfasigma. comTel: 00800 7878 1345 English (EN) (255.89 KB – PDF) EMA/PE/0000232302: EMA decision of 16 April 2025 on the acceptance of a modification of an agreed paediatric investigation plan for filgotinib maleate (Jyseleca)

Produk Berkaitan Artikel Ini

Produk ini dipadankan secara automatik berdasarkan tajuk, ringkasan, dan kandungan artikel.

Soalan Lazim

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Filgotinib – Beli Dalam Talian.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.

WhatsApp WhatsApp WeChat WeChat